Adesh Kaul
Director of Finance/CFO bij BASILEA PHARMACEUTICA AG
Vermogen: 20 900 $ op 31-03-2024
Actieve functies van Adesh Kaul
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BASILEA PHARMACEUTICA AG | Director of Finance/CFO | 10-04-2019 | - |
Investor Relations Contact | 01-01-2009 | - | |
Public Communications Contact | 01-01-2009 | - | |
Corporate Officer/Principal | - | 10-04-2019 |
Loopbaan van Adesh Kaul
Eerdere bekende functies van Adesh Kaul
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SPEXIS AG | Director of Finance/CFO | 01-01-2015 | 01-01-2016 |
NZB Neue Zürcher Bank AG (Investment Management)
NZB Neue Zürcher Bank AG (Investment Management) Major BanksFinance NZB Neue Zürcher Bank AG/Investment Management (NZB-IM) is the investment management division of NZB Neue Zürcher Bank AG, in turn a subsidiary of Bank Sarasin & Cie AG. The activities of NZB Neue Zürcher Bank AG include brokerage, asset management and investment advisory services. Founded in 2000, the firm is based in Zurich, Switzerland. Clients include institutional investors and private individuals from Switzerland and worldwide. NZB-IM managed a Swiss-domiciled fund until 2009 when they ceased their asset management activities. | Analyst-Equity | - | - |
NZB Neue Zürcher Bank AG
NZB Neue Zürcher Bank AG Investment Banks/BrokersFinance NZB Neue Zürcher Bank AG is a majority-owned subsidiary of MainFirst Schweiz AG, itself a subsidiary of MainFirst Holding AG in Switzerland. Founded in 2000 and based in Zurich, NZB absorbed the brokerage business of Bank Sarasin & Cie AG in 2007, which led Bank Sarasin to hold a 40% stake in NZB. In 2009 they increased their shareholding to a majority interest. NZB Neue Zürcher Bank AG provides primarily brokerage services. Up until 2009 they also had an asset management and investment advisory department. Their clients include Swiss and international institutional investors as well as private individuals. | Analyst-Equity | - | - |
Opleiding van Adesh Kaul
University of St. Gallen | Masters Business Admin |
University of Basel | Graduate Degree |
Statistieken
Internationaal
Zwitserland | 7 |
Operationeel
Analyst-Equity | 2 |
Director of Finance/CFO | 2 |
Investor Relations Contact | 1 |
Sectoraal
Finance | 3 |
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BASILEA PHARMACEUTICA AG | Health Technology |
SPEXIS AG | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
NZB Neue Zürcher Bank AG (Investment Management)
NZB Neue Zürcher Bank AG (Investment Management) Major BanksFinance NZB Neue Zürcher Bank AG/Investment Management (NZB-IM) is the investment management division of NZB Neue Zürcher Bank AG, in turn a subsidiary of Bank Sarasin & Cie AG. The activities of NZB Neue Zürcher Bank AG include brokerage, asset management and investment advisory services. Founded in 2000, the firm is based in Zurich, Switzerland. Clients include institutional investors and private individuals from Switzerland and worldwide. NZB-IM managed a Swiss-domiciled fund until 2009 when they ceased their asset management activities. | Finance |
NZB Neue Zürcher Bank AG
NZB Neue Zürcher Bank AG Investment Banks/BrokersFinance NZB Neue Zürcher Bank AG is a majority-owned subsidiary of MainFirst Schweiz AG, itself a subsidiary of MainFirst Holding AG in Switzerland. Founded in 2000 and based in Zurich, NZB absorbed the brokerage business of Bank Sarasin & Cie AG in 2007, which led Bank Sarasin to hold a 40% stake in NZB. In 2009 they increased their shareholding to a majority interest. NZB Neue Zürcher Bank AG provides primarily brokerage services. Up until 2009 they also had an asset management and investment advisory department. Their clients include Swiss and international institutional investors as well as private individuals. | Finance |
- Beurs
- Insiders
- Adesh Kaul
- Ervaring